PACTR201508001191898
Completed
未知
Validation of New Biomarkers for Monitoring Plasmodium falciparum Reduced susceptibility/Tolerance or Resistance to Artemisinin Derivatives and Partner Drugs in Nigeria.
EDCTP0 sites0 target enrollmentJuly 7, 2015
ConditionsMalaria
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Malaria
- Sponsor
- EDCTP
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Symptoms compatible with acute uncomplicated malaria with pure Plasmodium falciparum parasitemia.
- •Microscopically confirmed P. falciparum infection with parasite density ¿ 2,000/¿l of blood
- •Body (axillary) temperature \> 37\.4oC or history of fever 24 ¿ 48 hours preceding presentation.
- •No have other concomitant illness.
- •No history of antimalarial use in the two weeks preceding presentation.
- •Ability and willingness to comply with the protocol for the duration of the study and to comply with the study visit schedule.
- •Written informed consent given by parents or guardians.
Exclusion Criteria
- •Severe malaria
- •Severe malnutrition.
- •Serious underlying disease (renal, cardiac, hepatic)
- •Concomitant febrile illness.
- •Known allergy to study drug or its components.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
In vivo study to monitor the sensitivity of Plasmodium falciparum and other species to Pyronaridineartesunate and Artemether-lumefantrine in Niger.PACTR202105706263530European and Developping Countries Clinical Trials partnership EDCTP240
Active, not recruiting
Not Applicable
Identification of predictive plasma Biomarkers and use of a high dosage statin during a procedure of Parrossistic Atrial Fibrillation CardioversioEUCTR2012-001260-29-ITFONDAZIONE ISTITUTO SAN RAFFAELE-G.GIGLIO
Unknown
Not Applicable
The establishment of clinical markers using plasma aminogram in the patients of inflammatory bowel diseaseJPRN-UMIN000001484Department of Internal Medicine, School of Medicine, Keio University1,300
Terminated
Not Applicable
Plasma Biomarkers P-DAC, V1Pancreatic Ductal AdenocarcinomaNCT02050997Cancer Trials Ireland169
Not yet recruiting
Not Applicable
Clinical evaluation of new biomarkers in diagnosis of valproate-induced renal tubular dysfunction.EpilepsyJPRN-UMIN000015787Department of Pediatrics, Kansai medical university100